Postpartum Depression: 1 in 7 Mothers Get It — Most Never Ask for Help

By Health 656 Editorial Team 2026-03-23 10 min read

You imagined motherhood would feel joyful. Instead, you feel empty. You stare at your baby and feel nothing — or worse, you feel resentment, rage, or terror. You cry for no reason. You cannot sleep even when the baby sleeps. You have intrusive thoughts that horrify you. You are convinced you are a terrible mother and that everyone would be better off without you. Postpartum depression (PPD) affects roughly 1 in 7 new mothers according to the American Psychological Association — approximately 600,000 women annually in the United States alone. A study in JAMA Psychiatry found that when broader screening criteria are used, up to 1 in 5 women experience significant depressive symptoms in the first year after delivery. PPD is not weakness. It is not a character flaw. It is a medical condition driven by hormonal, neurochemical, and psychological changes that are among the most extreme the human body undergoes. And it is highly treatable — if women can overcome the shame and silence that prevent them from asking for help.

What Is Happening in Your Brain and Body

During pregnancy, estrogen and progesterone levels rise to 10 to 100 times their normal levels. Within 24 to 48 hours of delivery, they plummet to near-zero — the most dramatic hormonal shift a human body experiences. These hormones directly affect serotonin, dopamine, GABA, and other neurotransmitters that regulate mood, bonding, sleep, and anxiety. The brain is essentially recalibrating its entire neurochemical landscape in the midst of sleep deprivation, physical recovery, and the overwhelming demands of a newborn.

A study in Molecular Psychiatry found that women who developed PPD had measurably different patterns of neurosteroid (allopregnanolone) decline after delivery compared to women who did not. This neurosteroid acts on GABA receptors — the same system targeted by anti-anxiety medications. When allopregnanolone drops too rapidly, the brain's calming system fails, producing anxiety, insomnia, and depressive symptoms.

The biological vulnerability interacts with psychological and social risk factors: history of depression or anxiety (the strongest predictor — 30 to 35 percent recurrence risk), lack of social support, relationship stress, traumatic birth experience, NICU admission, breastfeeding difficulties, history of trauma or abuse, and unplanned pregnancy.

A 32-year-old lawyer described her experience: "I had no history of depression. I wanted this baby more than anything. But 3 weeks after delivery, I felt nothing. I went through the motions — feeding, changing, rocking — like a robot. I was terrified to be alone with my baby, not because I thought I would hurt her, but because I was terrified something would happen and I would not be able to cope. My husband said 'you seem fine' because I was functioning. But inside I was drowning."

Baby Blues vs Postpartum Depression — The Critical Distinction

Baby blues affect 50 to 80 percent of new mothers. Symptoms include mood swings, tearfulness, irritability, and feeling overwhelmed — starting 2 to 3 days after delivery and resolving within 2 weeks. This is a normal response to hormonal shifts, sleep deprivation, and the adjustment to parenthood. No treatment is needed beyond rest, support, and reassurance.

Postpartum depression is different in severity, duration, and impact. It can begin anytime in the first year after delivery (not just the first weeks), lasts more than 2 weeks, and significantly impairs the ability to function or bond with the baby. Symptoms include persistent sadness or emptiness, inability to enjoy things you used to enjoy, excessive guilt (especially about mothering), withdrawing from the baby, partner, or friends, severe anxiety or panic attacks, changes in appetite, difficulty sleeping even when the baby sleeps, difficulty concentrating or making decisions, thoughts of self-harm or harming the baby (these are more common than most people realize and do not mean you are dangerous — they are symptoms that require treatment).

Postpartum psychosis is rare (1 to 2 per 1,000 births) but a psychiatric emergency. Symptoms include hallucinations, delusions, extreme confusion, paranoia, and erratic behavior. It typically appears within the first 2 weeks and requires immediate hospitalization. If you or someone you know is experiencing these symptoms, call 911 or go to the nearest emergency department.

Why Women Do Not Get Help

A study in the Journal of Affective Disorders found that fewer than 50 percent of women with PPD receive any treatment. The barriers are profound: shame (the expectation that motherhood should be blissful), fear of judgment (being seen as an unfit mother), fear of having the baby taken away, not recognizing that symptoms are abnormal (attributing everything to sleep deprivation and adjustment), healthcare system failures (OB appointments ending at 6 weeks postpartum, with inadequate mental health screening), and minimization by partners, family, and even healthcare providers ("all new moms feel tired").

The Edinburgh Postnatal Depression Scale (EPDS) is a validated 10-question screening tool that takes 5 minutes to complete. The American College of Obstetricians and Gynecologists (ACOG) recommends screening at least once during the perinatal period. A study in Obstetrics and Gynecology found that universal screening with the EPDS doubled the detection rate of PPD. If your OB has not screened you, ask for the screening. If you score above 12, you need evaluation.

Treatment — Highly Effective When Women Access It

Therapy: Cognitive behavioral therapy (CBT) and interpersonal therapy (IPT) are both highly effective. A meta-analysis in the Journal of Consulting and Clinical Psychology found that therapy reduced PPD symptoms by 50 to 70 percent. IPT, which focuses on role transitions, relationship changes, and social support, is particularly well-suited to the postpartum period.

Medication: SSRIs (sertraline, escitalopram) are the first-line pharmacological treatment. Sertraline is the most commonly prescribed because it has the lowest passage into breast milk and the most breastfeeding safety data. A study in the New England Journal of Medicine found that sertraline was significantly more effective than placebo for PPD, with response rates of 53 percent versus 28 percent. Most SSRIs are compatible with breastfeeding — the benefits of treating maternal depression far outweigh the minimal infant exposure.

Brexanolone (Zulresso): The first FDA-approved treatment specifically for PPD, administered as a 60-hour IV infusion. It is a synthetic form of allopregnanolone — the exact neurosteroid that drops after delivery. A study in The Lancet found that 75 percent of women treated with brexanolone achieved remission by day 30. Due to the IV requirement, it is administered in certified healthcare facilities. Zuranolone (Zurzuvae): The first oral medication approved specifically for PPD — a 14-day course of daily pills. The SKYLARK trial found significant improvement in depressive symptoms within 3 days.

Support interventions: Partner involvement, postpartum support groups, peer counseling, home visiting programs, and postpartum doulas all improve outcomes. Sleep protection — having a partner or family member take one full nighttime feeding shift so the mother gets a 4 to 5-hour uninterrupted sleep block — can be transformative. Sleep deprivation is both a symptom and a driver of PPD.

A 28-year-old nurse recognized her PPD symptoms at 6 weeks postpartum because of her medical training. Even so, she waited 3 more weeks to seek help because of shame. "I take care of sick people for a living," she said. "Admitting I could not take care of myself and my baby felt like the ultimate failure." She started sertraline and weekly therapy. Within 6 weeks, she described feeling like herself again. "I finally looked at my daughter and felt love instead of fear. That moment made me wish I had asked for help on day one."

Common Questions

Will postpartum depression affect my baby?

Untreated PPD can affect infant bonding, development, and emotional regulation. But treated PPD does not cause lasting harm. Treatment benefits both mother and baby. A study found that infants of mothers whose PPD was effectively treated showed normal developmental outcomes. Getting help is the most important thing you can do for your baby.

Can I breastfeed while taking antidepressants?

Yes. Sertraline and several other SSRIs have extensive safety data in breastfeeding and are considered compatible by the American Academy of Pediatrics. The amount passing into breast milk is minimal. Untreated maternal depression poses greater risks to the infant than SSRI exposure through breast milk.

Can fathers get postpartum depression?

Yes. A meta-analysis in JAMA found that roughly 8 to 10 percent of fathers experience depression in the first year after their child's birth. Paternal PPD is driven by sleep deprivation, relationship stress, role adjustment, and hormonal changes (testosterone drops in new fathers). Treatment is the same — therapy and medication when needed.

Will PPD happen again with my next baby?

The recurrence risk is roughly 30 to 50 percent. However, with awareness and a proactive plan — including early screening, mental health support arranged before delivery, sleep protection strategies, and possibly preventive medication in high-risk women — many women have subsequent pregnancies without PPD.

postpartum-depression womens-health mental-health pregnancy motherhood

Supplements

How to Read Your Cholesterol Numbers: What LDL, HDL, and Triglycerides Actually Mean

2026-04-04 10 min read